刘杨,陈利琴,王文斌,缪文青,黄明,陈大平
LIU Yang,CHEN Linqin,WANG Wenbin,MIAO Wenqin,HUANG Ming,CHEN Daping

• 1:咸宁市中心医院甲乳外科

摘要(Abstract)：

目的:探讨血浆中白细胞介素(IL)-6、IL-8及肿瘤坏死因子-α(TNF-a)与乳腺癌发生发展、临床分期及骨转移的关系。方法:111例乳腺肿瘤患者根据病理结果分为乳腺良性肿瘤组(n=50)、乳腺癌组(n=61),50例健康妇女作为正常对照组,采用酶联免疫吸附(ELISA)法分别检测3组患者血浆中IL-6、IL-8及TNF-α的水平,分析3项指标与乳腺癌临床分析、肿瘤转移以及年龄(≥50岁和<50岁)的关系。结果:乳腺癌组血浆IL-6、IL-8及TNF-α水平明显高于良性肿瘤组和正常对照组(P<0.05);随着乳腺癌临床分期的提高,IL-6、IL-8及TNF-α水平逐渐升高(P<0.05);乳腺癌骨转移患者血浆IL-6、IL-8及TNF-α水平明显高于乳腺癌无转移及乳腺癌其他脏器转移患者(P<0.05);年龄对乳腺癌患者血清IL-6、IL-8及TNF-α水平影响不大(P>0.05)。结论:血清IL-6、IL-8及TNF-α水平与乳腺癌的发生发展有关。
Objective: To discussthe relationship between plasma interleukin( IL)-6,IL-8 and tumor necrosis factor-α( TNF-α) and the development,clinical stage and bone metastasis of breast cancer.Methods: According to the pathological results,111 cases of breast cancer patientswere divided into benign breast tumor group( n = 50),breast cancer group( n = 61),50 healthy women as control group. Plasma IL-6,IL-8 and TNF-α levels of normal control group,breast benign tumor group and breast cancer of 3 groups were measured by enzyme-linked immunosorbent( ELISA). Then their correlation with clinical biological characteristics of breast cancer was analyzed. Results: Plasma IL-6,IL-8 and TNF-α levels in breast cancer group were significantly higher than those in benign tumor group( P < 0. 05) and normal control group( P < 0. 05). With the increase of clinical stage of breast cancer,IL-6,IL-8 and TNF-α levels increased gradually,and difference between each clinical stage was statistically significant( P < 0. 05). Plasma IL-6,IL-8 and TNF-α levels of bone metastasis patients in breast cancer group were significantly higher than those in patients without metastasis and in breast cancer patients with other organ metastasis( P < 0. 05). The influence of age on plasma IL-6,IL-8 and TNF-α levels was not significant( P > 0. 05). Conclusion: Plasma IL-6,IL-8 and TNF-αlevels may be associated with the development of breast cancer.

关键词(KeyWords)： 白细胞介素-6;白细胞介素-8;肿瘤坏死因子-α;乳腺肿瘤;肿瘤转移
interleukin-6;interleukin-8;tumor necrosis factor-α;breast neoplasms;neoplasm metastasis

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 刘杨,陈利琴,王文斌,缪文青,黄明,陈大平
LIU Yang,CHEN Linqin,WANG Wenbin,MIAO Wenqin,HUANG Ming,CHEN Daping

DOI: 10.19367/j.cnki.1000-2707.2016.03.030

参考文献(References)：

• [1]Standish LJ,Sweet ES,Novack J,et al.Breast cancer and the immune system[J].Soc Integr Oncol,2008(4):158-168.
• [2]李美江.白细胞介素基因多态性与乳腺癌遗传易感性的研究进展[J].右江民族医学院学报,2013(3):373-375.
• [3]Culig Z,Steiner H,Bartsch G,et al.Interleukin-6 regulation of prostate cancer cell growth[J].J Cen Biochem,2005(3):497-505.
• [4]Ycchimura K,Laird LS,Chia CY,et al.Live attenuated Listeria monocytogenes effectively treats hepatic coloreetal cancer metastases and is strongly enhanced by depletion ofregulatory T cells[J].Cancer Res,2007(20):10058-10066.
• [5]Andrews B.Shariat SF Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of aptients with bladder cancer[J].Jonmal of Drology,2002(3):1475-1481.
• [6]Rachel L,Richard L.Biology of bone metastases[J].Cancer Control,2012(2):93-101.
• [7]Elvira Crarza-Gonzalez E,Francisco J,Bosques-Padilla FJ.Assessment of the toll-like receptor 4 Asp299Gly,Thr399Ile and in-terleukin-8-251 polymorphisms in the risk for the development of distal gastric cancer[J].BMC Cancer,2007(8):70-76.
• [8]Green AR,Green VL,White MC,et al.Expression of cytokine messenger RNA in normal and neoplastic human breast tissue:Indentification of interleukin-8 as a potential regulatory factor in breast tumors[J].Int J Cancer,1997(6):937.
• [9]计蓓,徐靖宇,庹必光.肿瘤坏死因子-α在恶性肿瘤发生发展中的作用及研究进展[J].贵州医药,2013(4):3 70-372.
• [10]金莉.宫颈癌患者血浆中NO和TNF-α的临床意义[J].浙江创伤外科,2011(3):291.

文章评论(Comment)：